Why MedDRA Coding and Safety Data Quality Matter More Than Most Pharmacovigilance Teams Realize

Key Takeaways

MedDRA coding directly influences signal detection, aggregate reporting, benefit-risk evaluation, and regulatory submissions.
Poor coding quality can distort safety trends and create misleading regulatory conclusions.
Consistency is often more important than coding speed in large pharmacovigilance operations.
Inspectors increasingly review coding governance, coding conventions, and quality control programs.
Strong safety data quality begins long before data enters a pharmacovigilance database.

Every pharmacovigilance system depends on data. Signal detection, aggregate reporting, benefit-risk assessments, inspections, and regulatory decisions all rely on the assumption that safety data is accurate, consistent, and meaningful.

At the center of this process sits MedDRA.

The Medical Dictionary for Regulatory Activities provides the standardized terminology used worldwide for coding adverse events, medical history information, indications, investigations, and other medically relevant information.

While coding may appear to be a technical database activity, it has far-reaching consequences across the entire pharmacovigilance lifecycle.

Incorrect coding can affect signal detection, distort aggregate reports, trigger inspection findings, and ultimately influence regulatory decisions.

This is why modern regulators increasingly view coding quality as a critical component of pharmacovigilance system integrity.

1. What Is MedDRA and Why Was It Created?

Before MedDRA became widely adopted, different organizations often used different medical terminologies when describing adverse events.

This created major challenges for:

Data comparison
Signal detection
Global reporting
Regulatory submissions

MedDRA was developed to provide a standardized international medical terminology.

Today it supports:

Pharmaceutical companies
Regulatory agencies
Clinical research organizations
Safety database providers
Academic researchers

Using a common language allows safety information from different countries and sources to be evaluated consistently.

This standardization forms the foundation of modern pharmacovigilance data analysis.

2. Understanding the MedDRA Hierarchy

One reason MedDRA is so powerful is its structured hierarchy.

Medical concepts are organized into multiple levels.

These include:

Lowest Level Terms (LLTs)
Preferred Terms (PTs)
High Level Terms (HLTs)
High Level Group Terms (HLGTs)
System Organ Classes (SOCs)

This hierarchical structure allows organizations to analyze safety data at different levels of detail.

For example:

A single adverse event can be reviewed individually at PT level.
Multiple related events can be analyzed collectively at higher levels.

Signal detection activities frequently rely on these hierarchical relationships to identify emerging safety patterns.

3. Why Coding Quality Directly Affects Signal Detection

Signal detection depends on identifying patterns within large volumes of safety data.

If coding is inconsistent, meaningful patterns may become difficult to recognize.

Examples of coding-related signal risks include:

Similar events coded differently
Loss of clinical specificity
Overly broad coding
Incorrect PT selection

Consider a situation where similar cardiac events are coded using multiple unrelated terms.

The resulting signal may appear weaker than it actually is because cases become fragmented across different categories.

Consistent coding therefore plays a direct role in the ability to identify emerging safety concerns.

4. Common Coding Errors Seen During Inspections

Inspectors increasingly review coding quality as part of broader pharmacovigilance assessments.

Common deficiencies include:

Inconsistent coding practices
Incorrect term selection
Failure to follow coding conventions
Overcoding
Undercoding

Overcoding occurs when coders assign terms that imply more clinical certainty than the source information supports.

Undercoding occurs when important medical detail is lost because terms are too general.

Both situations can affect downstream safety analyses and regulatory interpretations.

Inspectors often evaluate whether organizations maintain sufficient controls to ensure coding consistency.

5. Coding Governance and Coding Conventions

Large pharmacovigilance organizations often process thousands of cases every month.

Without clear governance, coding variability can increase rapidly.

Many companies therefore establish:

Coding conventions
Coding guidance documents
Medical review procedures
Coding oversight committees

Coding conventions help standardize decisions across different coders and geographic regions.

Examples include guidance on:

Product quality complaints
Medication errors
Laboratory abnormalities
Pregnancy exposures
Special situations

Strong governance helps maintain consistency as organizations grow.

6. Safety Data Quality Beyond Coding

Although coding is important, safety data quality extends far beyond MedDRA term selection.

Quality concerns may involve:

Incomplete narratives
Missing dates
Incorrect demographics
Duplicate cases
Inconsistent seriousness assessments
Poor follow-up practices

Signal detection systems can only be as reliable as the underlying data.

Weak data quality often creates noise that makes meaningful signal identification more difficult.

This is why many organizations maintain dedicated data quality monitoring programs.

7. The Relationship Between Coding and Aggregate Reporting

Aggregate reports rely heavily on coded safety data.

PSURs, PBRERs, and DSURs frequently use coded information to:

Identify trends
Evaluate risks
Compare reporting frequencies
Assess safety profiles

Inconsistent coding may therefore affect:

Signal discussions
Benefit-risk conclusions
Regulatory submissions
Scientific interpretation

Organizations preparing aggregate reports often perform additional quality reviews to ensure coding consistency.

Inspectors may compare aggregate report conclusions against underlying coded datasets.

8. Data Quality Metrics and Quality Control Programs

Many mature pharmacovigilance organizations monitor safety data quality through structured metrics programs.

Examples include:

Coding accuracy rates
QC findings
Duplicate detection rates
Narrative quality metrics
Follow-up completion rates

Quality control activities may involve:

Case reviews
Coding consistency checks
Medical reviews
Audit activities

Regular monitoring helps identify recurring weaknesses before they affect regulatory compliance.

Inspectors increasingly expect organizations to demonstrate active oversight of data quality.

9. Technology, AI, and Automated Coding

Modern pharmacovigilance systems increasingly use automation and artificial intelligence to support coding activities.

Applications include:

Suggested coding terms
Duplicate detection
Data quality monitoring
Workflow prioritization

Automation can improve efficiency, but regulators continue emphasizing human oversight.

Organizations remain responsible for:

Validation
Governance
Quality review
Data integrity

Technology should support expert judgment rather than replace it.

10. Building a Strong Safety Data Quality Culture

The most successful pharmacovigilance organizations recognize that data quality is not solely the responsibility of coders or quality teams.

Data quality begins when information is first received and continues throughout the entire safety lifecycle.

Strong organizations typically demonstrate:

Clear coding governance
Effective quality controls
Continuous training
Regular audits
Management oversight
Risk-based monitoring

Ultimately, reliable safety decisions depend on reliable safety data.

Organizations that prioritize data quality strengthen every aspect of their pharmacovigilance systems, from case processing to regulatory inspections.

Related Resources

FAQs

What is MedDRA?

MedDRA is the Medical Dictionary for Regulatory Activities, a standardized international terminology used for coding medical information in pharmacovigilance and clinical research.

Why is coding consistency important?

Consistent coding improves signal detection, aggregate reporting quality, and regulatory analysis.

What is overcoding?

Overcoding occurs when a selected term implies greater clinical certainty or specificity than the source information supports.

Do inspectors review MedDRA coding?

Yes. Inspectors increasingly review coding practices, governance systems, and coding quality controls.

Can AI replace medical coders?

No. AI can support coding activities, but human medical judgment remains essential for accurate coding decisions.

Inspection Readiness Notes

Maintain documented coding conventions and governance procedures.
Perform periodic coding consistency reviews.
Trend coding-related QC findings and recurring issues.
Ensure MedDRA version updates are implemented appropriately.
Verify that aggregate reporting conclusions align with coded safety data.

MedDRA Coding & Safety Data Quality